Maturation and inhibitor design of SARS-CoV 3CL protease based on a product-bound crystal structure

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2005年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
  • [21] SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
    Muramatsu, Tomonari
    Takemoto, Chie
    Kim, Yong-Tae
    Wang, Hongfei
    Nishii, Wataru
    Terada, Takaho
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) : 12997 - 13002
  • [22] Crystallization of SARS Coronavirus 3CL Protease to Identify Inhibitor Targets
    Fernandes, Samantha Zinnia
    Anson, Brandon
    Mesecar, Andrew
    [J]. FASEB JOURNAL, 2019, 33
  • [23] The Interaction of Antiviral Drugs with SARS-Cov-2 3CL Protease
    Saadh, Mohamed J.
    [J]. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (03) : 865 - 868
  • [24] Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib
    Niesor, Eric J.
    Boivin, Guy
    Rheaume, Eric
    Shi, Rong
    Lavoie, Veronique
    Goyette, Nathalie
    Picard, Marie-Eve
    Perez, Anne
    Laghrissi-Thode, Fouzia
    Tardif, Jean-Claude
    [J]. ACS OMEGA, 2021, 6 (25): : 16584 - 16591
  • [25] Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor
    Katsube, Takayuki
    Kezbor, Safwan
    Shimizu, Ryosuke
    Kubota, Ryuji
    [J]. INFECTIOUS DISEASES AND THERAPY, 2024, 13 (03) : 597 - 607
  • [26] Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
    Su, Haixia
    Yao, Sheng
    Zhao, Wenfeng
    Zhang, Yumin
    Liu, Jia
    Shao, Qiang
    Wang, Qingxing
    Li, Minjun
    Xie, Hang
    Shang, Weijuan
    Ke, Changqiang
    Feng, Lu
    Jiang, Xiangrui
    Shen, Jingshan
    Xiao, Gengfu
    Jiang, Hualiang
    Zhang, Leike
    Ye, Yang
    Xu, Yechun
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [27] Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
    Haixia Su
    Sheng Yao
    Wenfeng Zhao
    Yumin Zhang
    Jia Liu
    Qiang Shao
    Qingxing Wang
    Minjun Li
    Hang Xie
    Weijuan Shang
    Changqiang Ke
    Lu Feng
    Xiangrui Jiang
    Jingshan Shen
    Gengfu Xiao
    Hualiang Jiang
    Leike Zhang
    Yang Ye
    Yechun Xu
    [J]. Nature Communications, 12
  • [28] Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors
    Bao, Hong-Lei
    Tu, Gao
    Yue, Qiu
    Liu, Pei
    Zheng, Hui-Li
    Yao, Xiao-Jun
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (04) : 857 - 869
  • [29] SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3
    Griffin, Jeddidiah W. D.
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2020, 211 (03)
  • [30] Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
    Akaji, Kenichi
    Konno, Hiroyuki
    Mitsui, Hironori
    Teruya, Kenta
    Shimamoto, Yasuhiro
    Hattori, Yasunao
    Ozaki, Takeshi
    Kusunoki, Masami
    Sanjoh, Akira
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) : 7962 - 7973
12345